Literature DB >> 11065203

Effects of remifentanil on neutrophil adhesion, transmigration, and intercellular adhesion molecule expression.

R Hofbauer1, M Frass, B Gmeiner, N Sandor, R Schumann, O Wagner, A D Kaye.   

Abstract

BACKGROUND: Anaesthetic drugs are used for pain therapy and anaesthesia. Neutrophils play a significant role during the process of inflammation. The aim of the current study was to investigate the effects of remifentanil and fentanyl on neutrophil migration through endothelial cell monolayers, and on adhesion molecule expression.
METHODS: After isolation of polymorphonuclear neutrophils (PMNL) we used a currently described migration assay. PMNL and/or endothelial cell monolayers (ECM) were pre-treated with remifentanil using clinically relevant, as well as higher and lower concentrations or relevant concentrations of fentanyl.
RESULTS: Concentrations of remifentanil (50 ng/mL) similar to the relevant plasma concentration were able to inhibit PMNL migration through ECM significantly (migration compared to the control 82+/-7% SD; P<0.05), when both cell types were treated with the synthetic narcotic remifentanil. Fentanyl (30 ng/mL) showed a stronger inhibitory effect (migration compared to the control 67+/-9.2%; P<0.05). Endothelial cell adhesion molecule expression was reduced after either remifentanil or fentanyl.
CONCLUSION: The results of the present investigation indicate that remifentanil influences interaction of ECM against human neutrophils. Compared to fentanyl, remifentanil seems to exhibit minor inhibitory effects on neutrophil migration.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11065203     DOI: 10.1034/j.1399-6576.2000.441008.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  12 in total

Review 1.  Immunosuppressive aspects of analgesics and sedatives used in mechanically ventilated patients: an underappreciated risk factor for the development of ventilator-associated pneumonia in critically ill patients.

Authors:  Michael A Smith; Maho Hibino; Bonnie A Falcione; Katherine M Eichinger; Ravi Patel; Kerry M Empey
Journal:  Ann Pharmacother       Date:  2013-11-04       Impact factor: 3.154

Review 2.  The Impact of General Anesthesia on Redox Stability and Epigenetic Inflammation Pathways: Crosstalk on Perioperative Antioxidant Therapy.

Authors:  Stelian Adrian Ritiu; Alexandru Florin Rogobete; Dorel Sandesc; Ovidiu Horea Bedreag; Marius Papurica; Sonia Elena Popovici; Daiana Toma; Robert Iulian Ivascu; Raluca Velovan; Dragos Nicolae Garofil; Dan Corneci; Lavinia Melania Bratu; Elena Mihaela Pahontu; Adriana Pistol
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

3.  Remifentanil attenuates lipopolysaccharide-induced acute lung injury by downregulating the NF-κB signaling pathway.

Authors:  Ying Zhang; Zhaohui Du; Qing Zhou; Yanlin Wang; Jianguo Li
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

4.  Protective effects of remifentanil on septic mice.

Authors:  Zhang Zongze; Zhan Jia; Chen Chang; Chen Kai; Wang Yanlin
Journal:  Mol Biol Rep       Date:  2009-09-15       Impact factor: 2.316

5.  The Effects of Fentanyl on Testicular Ischemia-Reperfusion Injury.

Authors:  Cengiz Mordeniz; Mahluga Jafarova Demirkapu; Hacı Murat Akgul; Sevil Karabag; Aliye Celikkol; Hasan Raci Yananlı
Journal:  Turk J Anaesthesiol Reanim       Date:  2021-10

6.  The Effects of Remifentanil on Expression of High Mobility Group Box 1 in Septic Rats.

Authors:  Kwon Hui Seo; Jin Woo Choi; Hong Soo Jung; Hansol Yoo; Jin Deok Joo
Journal:  J Korean Med Sci       Date:  2017-03       Impact factor: 2.153

7.  Remifentanil-induced alterations in neutrophil numbers after surgery.

Authors:  Toshiichro Inagi; Hideko Hoshina; Manzo Suzuki; Miki Wada; Hiroyasu Bito; Atsuhiro Sakamoto
Journal:  JA Clin Rep       Date:  2016-04-02

Review 8.  Do All Opioid Drugs Share the Same Immunomodulatory Properties? A Review From Animal and Human Studies.

Authors:  Silvia Franchi; Giorgia Moschetti; Giada Amodeo; Paola Sacerdote
Journal:  Front Immunol       Date:  2019-12-12       Impact factor: 7.561

9.  Remifentanil Protects against Lipopolysaccharide-Induced Inflammation through PARP-1/NF-κB Signaling Pathway.

Authors:  Jian-Ning Zhang; Yang Ma; Xi-Yan Wei; Ke-Yin Liu; Hao Wang; Hui Han; Yi Cui; Ming-Xiang Zhang; Wei-Dong Qin
Journal:  Mediators Inflamm       Date:  2019-12-31       Impact factor: 4.711

10.  Remifentanil attenuates cardiac dysfunction, lipid peroxidation and immune disorder in rats with isoproterenol-induced myocardial injury via JNK/NF-KB p65 inhibition.

Authors:  Qin Zhou; Junmei Song; Yu Wang; Tao Lin
Journal:  Ann Transl Med       Date:  2020-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.